Autobahn Therapeutics | Biotech | Standout | Standout

Autobahn Therapeutics

2 employees

Biotech

Series C · $228.0M

Open positions (2)

Vice President, Medical Affairs and Professional Relations

San Diego, CA

Associate Director/ Director, Clinical Scientist

San Diego, CA

Company details

Team Size2

IndustryBiotech

Funding

Total raised

$228.0M

Last stage

Series C

Investors

ARCH Venture Partners

Newpath Partners

Canaan Partners

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Earn $3,000

ProductHow it works For talent For companies Browse jobs Browse companies

CompanyAbout Blog Careers

ConnectTwitter / X LinkedIn

Standout.

Privacy Terms

Insight Partners

Pfizer Ventures

Founders

Tom Scanlan

Researcher at OHSU whose lab originated Autobahn Therapeutics; developed brain-penetrating thyroid hormone receptor beta agonist molecules for CNS diseases.

Keith Lenden

Co-founded Autobahn Therapeutics alongside Tom Scanlan; listed as Founder and President by CB Insights.

Kevin Finney

Experienced biopharma executive; former President & COO of Abide Therapeutics and co-founder of Zavante Therapeutics. Leads Autobahn as President and Chief Executive Officer.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.